Clinical Trials Logo

Total Shoulder Athroplasty clinical trials

View clinical trials related to Total Shoulder Athroplasty.

Filter by:
  • None
  • Page 1

NCT ID: NCT04560010 Terminated - Clinical trials for Total Shoulder Athroplasty

TXA in Anticoagulated Patients Study

Start date: October 6, 2020
Phase: Phase 4
Study type: Interventional

This is a randomized, single-blind, single-center study comparing calculated total blood loss, surgical drain output and hematoma formation in anticoagulated patients who receive 2 doses of Tranexamic Acid (TXA) versus control group undergoing anatomical and reverse total shoulder arthroplasty (TSA). Patients will be randomized to either receive 2 doses of IV TXA, first dose prior to surgical incision and second dose given 3 hours later or to the control group, where no TXA will be administered.